Search Results - Diabetes

4 Results Sort By:
PEGylated Bilirubin for the treatment of Hyperlipidemia, Obesity, and Type II Diabetes
Project ID: D2018-40Background:Obesity, a low-grade inflammatory disease, has affected more than 150 million people in the US. Obesity and its associated risk factors are a prelude to the development of type II diabetes that accounts for a vast majority of the 25.8 million diabetes cases in the US. Bilirubin, a yellow pigment produced during red blood...
“Thin” Molecules for Treating Obesity and Type II Diabetes
Project ID: D2016-29IP Status: PCT patent application filedInvention Description and Novelty: “Thin” molecules offer stronger binding to PPAR and include greater lipid burning and glucose lowering properties. Applications: Dyslipidemia, obesity and type II diabetes Value propositions: • Bilirubin reduces body fat percentage...
Generation of Stable iTregs as Therapeutics against Autoimmune Diseases (Type I Diabetes)
Project ID: D2010-30 Invention novelty: New methods for induction and expansion of stable iTregs without addition of exogenous TGF-βValue Proposition: The “anti-self” immune response in human body leads to development of autoimmune diseases. For example, Diabetes mellitus type 1 (formerly known as juvenile diabetes) results from autoimmune...
Amine-terminated Aptamer Functionalized SPR Sensor
Project ID: D2012-07 IP Status: Provisional Application Invention novelty and description: This novel invention describes sensors for target entities having at least one amine-terminated aptamer specific to the target entity. Aptamers are artificial oligonucleotides which can serve as antibody mimics because of their high affinity and selectivity for...